Cargando…
ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance
ADAM10 and ADAM17 expression and soluble PD-L1 (sPD-L1) predict poor prognosis in many malignancies, including in patients treated with PD-(L)1 inhibitors. The mechanism of soluble PD-L1 production and its effects are unknown. Here we uncover a novel mechanism of ADAM10- and ADAM17-mediated resistan...
Autores principales: | Orme, Jacob J., Jazieh, Khalid A., Xie, Tiancheng, Harrington, Susan, Liu, Xin, Ball, Matthew, Madden, Benjamin, Charlesworth, M. Cristine, Azam, Tariq U., Lucien, Fabrice, Wootla, Bharath, Li, Yanli, Villasboas, Jose Caetano, Mansfield, Aaron S., Dronca, Roxana S., Dong, Haidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185206/ https://www.ncbi.nlm.nih.gov/pubmed/32363112 http://dx.doi.org/10.1080/2162402X.2020.1744980 |
Ejemplares similares
-
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
por: Orme, Jacob J, et al.
Publicado: (2020) -
The Platelet Collagen Receptor GPVI Is Cleaved by Tspan15/ADAM10 and Tspan33/ADAM10 Molecular Scissors
por: Koo, Chek Ziu, et al.
Publicado: (2022) -
ADAM10-cleaved ephrin-A5 contributes to prostate cancer metastasis
por: Cai, Chenchen, et al.
Publicado: (2022) -
(1-Adamantyl)diphenylmethanol
por: Vícha, Robert, et al.
Publicado: (2010) -
Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)